Bioengineering companies
35 companies
LemVega Capital
Investing in pre-seed and seed stage biotech start-ups within a niche focus in bio-remediation, bioengineering, cell & gene therapy, and longevity.
Undeterred Capital
We partner with founders commercializing scientific and technological breakthroughs in biological platforms and applied robotics.
ONEBIO
Turning life science into business.
SOSV
Deep tech for human and planetary health
4BIO Capital
4BIO Capital is an international venture capital firm focused solely on the advanced therapies sector.
MBX Capital
Investing in good health, for everyone.
Emerald BioVentures
Emerald Bioventures was formed to incubate and build transformational life sciences companies with extraordinary entrepreneurs.
Bioqube Ventures
Investing in the future of healthcare.
BioGeneration Ventures
Early-stage funding for European life sciences companies.
SymBiosis
We are long-term investors in engineering biology to treat - or better, cure - human disease.
BioSTL
BioSTL drives collaborative efforts to advance innovation & entrepreneurship that build on St. Louis’ world-class medical & plant biosciences.
b.value AG
Investing in the core technologies of the future - for real innovations in fast-growing markets.
Biospring Partners
Driving innovation in life sciences technology. Biospring Partners is a growth equity firm leveraging deep sector experience to partner with leading companies o…
AdBio partners
We invest in and develop the most innovative early-stage startups in life sciences in Europe.
Bio&Tech Smart Capital
We promote the sustainable growth of the bio and tech sector.
Next Sequence
We help founders build the most disruptive companies at the edge of Synthetic Biology and A.I.
Bioluminescence Ventures
We're biomedical researchers investing in a new generation of translational founders.
Amino Collective
Amino Collective is a European VC partnering with seed stage founders where software, biology and healthcare converge.
OMX Ventures
Investing at the convergence of biology and computing to support a new generation of breakthrough technologies.
Biovance Capital
Investing in disruptive, early-stage biopharma companies across Europe.